Unseeded Scaffold Vascularization for Tissue Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current tissue engineering methods face challenges in achieving rapid vascularization and nutrient transport in large 3D scaffold constructs, leading to limited tissue ingrowth and accumulation of waste products from biodegradable scaffolds, which impede cell growth.
Innovation Solution
A method involving the temporal separation of blood vessel ingrowth and tissue ingrowth, where an unseeded scaffold is implanted and allowed to vascularize naturally before being seeded with tissue-regenerating cells, utilizing angiogenesis stimulating factors and biodegradable scaffolds with optimized degradation rates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If cells are seeded onto the scaffold prior to implantation, then tissue formation can begin immediately, but the scaffold cannot be properly vascularized leading to cell death and limited tissue ingrowth
Solution Approach 1:
The patent segments the tissue engineering process into distinct phases: first implanting the unseeded scaffold to establish vascularization, then separately introducing cells after the scaffold has developed adequate blood supply. This temporal separation resolves the contradiction by ensuring vascularization occurs before cell seeding, eliminating cell death from lack of nutrients while maintaining efficient tissue formation.
Solution Approach 2:
The scaffold is implanted and allowed to vascularize in advance before cells are introduced. This preliminary action of establishing blood vessels and nutrient transport pathways ensures that when cells are eventually seeded, they immediately receive necessary nutrients and oxygen, thereby improving both cell survival and subsequent tissue formation productivity.
2Reliability
If the scaffold is implanted early to allow vascularization, then nutrient transport is improved, but tissue ingrowth is delayed due to temporal separation of vascularization and tissue formation
Solution Approach 1:
The scaffold is implanted in advance to establish vascularization pathways before cell introduction. This preliminary action ensures adequate nutrient transport infrastructure is in place, and the subsequent cell seeding occurs in an optimized environment that accelerates tissue formation, ultimately reducing total repair time despite the phased approach.
Solution Approach 2:
The scaffold is designed to autonomously vascularize through the body's natural wound healing response when implanted unseeded. This self-service capability eliminates the need for complex external vascularization systems and allows the scaffold to prepare its own environment for subsequent cell introduction, improving nutrient transport without requiring additional time-consuming interventions.
3Productivity
If biodegradable scaffolds are used to provide temporary support, then tissue regeneration is facilitated, but waste product accumulation from degradation impedes cell growth
Solution Approach 1:
The scaffold is implanted and allowed to vascularize before cell seeding. During this pre-vascularization period, the scaffold begins controlled degradation and the developing vascular system establishes waste removal pathways. This preliminary action ensures that when cells are introduced, the scaffold's waste products are already being actively cleared by the vascularized tissue, preventing accumulation that would impede cell growth while maintaining the scaffold's regenerative support function.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the success and rate of tissue repair by allowing earlier scaffold implantation, leveraging the body's natural wound healing response for vascularization and optimizing nutrient transport, thereby improving cell survival and tissue regeneration.
Implementation Method 1
allowing said scaffold to be vascularized until a substantially sufficient fluid flow through said scaffold is assured for the transport of nutrients and/or waste products
Implementation Method 2
accumulation of waste products from biodegradable scaffolds, which impede cell growth
Data Source
AI summary
The present invention relates to a method of treating a tissue defect in a human or animal body comprising the steps of implanting into said body an unseeded scaffold; allowing or effecting a wound healing response at the site of said defect; allowing said scaffold to be vascularized until a substantially sufficient fluid flow through said scaffold is assured for the transport of nutrients and/or waste products, and seeding said vascularised scaffold with a suitable population of tissue-regenerating cells.